September 6, 2017 / 7:34 AM / in 2 months

BRIEF-Chiome Bioscience receives decision to grant TROP-2 antibody related patent in Europe

Sept 6 (Reuters) - Chiome Bioscience Inc

* Says it received a decision to grant patent for Anti-Human Trop-2 Antibody Having Antitumor Activity in Vivo,(application No. 11783675.9) in Europe, on Sept. 6

Source text in Japanese:goo.gl/WoYj1G

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below